IOL CHEMICALS & PHARM. | ADESHWAR MEDITEX | IOL CHEMICALS & PHARM./ ADESHWAR MEDITEX |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | - | - | View Chart |
P/BV | x | 1.6 | 1.3 | 118.8% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. ADESHWAR MEDITEX |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ADESHWAR MEDITEX Mar-23 |
IOL CHEMICALS & PHARM./ ADESHWAR MEDITEX |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 33 | 1,626.4% | |
Low | Rs | 272 | 17 | 1,625.1% | |
Sales per share (Unadj.) | Rs | 377.6 | 57.1 | 661.7% | |
Earnings per share (Unadj.) | Rs | 23.7 | 1.4 | 1,648.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 1.8 | 1,748.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 22.8 | 1,126.0% | |
Shares outstanding (eoy) | m | 58.71 | 14.43 | 406.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.4 | 245.7% | |
Avg P/E ratio | x | 17.1 | 17.3 | 98.6% | |
P/CF ratio (eoy) | x | 12.8 | 13.8 | 93.0% | |
Price / Book Value ratio | x | 1.6 | 1.1 | 144.4% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 359 | 6,614.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 13 | 12,618.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 824 | 2,692.1% | |
Other income | Rs m | 256 | 3 | 8,369.3% | |
Total revenues | Rs m | 22,427 | 827 | 2,713.1% | |
Gross profit | Rs m | 2,257 | 52 | 4,324.8% | |
Depreciation | Rs m | 462 | 5 | 8,693.0% | |
Interest | Rs m | 165 | 21 | 788.8% | |
Profit before tax | Rs m | 1,887 | 29 | 6,496.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 8 | 5,965.1% | |
Profit after tax | Rs m | 1,391 | 21 | 6,708.8% | |
Gross profit margin | % | 10.2 | 6.3 | 160.7% | |
Effective tax rate | % | 26.2 | 28.6 | 91.8% | |
Net profit margin | % | 6.3 | 2.5 | 249.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 596 | 1,622.7% | |
Current liabilities | Rs m | 5,025 | 314 | 1,602.6% | |
Net working cap to sales | % | 20.9 | 34.3 | 61.1% | |
Current ratio | x | 1.9 | 1.9 | 101.3% | |
Inventory Days | Days | 43 | 16 | 269.8% | |
Debtors Days | Days | 8 | 1,238 | 0.7% | |
Net fixed assets | Rs m | 11,017 | 73 | 15,055.2% | |
Share capital | Rs m | 587 | 144 | 406.8% | |
"Free" reserves | Rs m | 14,490 | 185 | 7,841.0% | |
Net worth | Rs m | 15,077 | 329 | 4,581.2% | |
Long term debt | Rs m | 0 | 23 | 0.0% | |
Total assets | Rs m | 20,684 | 669 | 3,092.2% | |
Interest coverage | x | 12.5 | 2.4 | 520.9% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 1.2 | 87.1% | |
Return on assets | % | 7.5 | 6.2 | 120.9% | |
Return on equity | % | 9.2 | 6.3 | 146.5% | |
Return on capital | % | 13.6 | 14.2 | 96.0% | |
Exports to sales | % | 26.7 | 6.1 | 437.7% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 50 | 11,782.4% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 50 | 11,782.4% | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 50 | -241.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 59 | 2,063.6% | |
From Investments | Rs m | -1,200 | -12 | 10,362.7% | |
From Financial Activity | Rs m | -41 | -48 | 85.9% | |
Net Cashflow | Rs m | -18 | 0 | 10,823.5% |
Indian Promoters | % | 48.2 | 42.7 | 113.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 57.4 | 90.3% | |
Shareholders | 130,003 | 179 | 72,627.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ADESHWAR MEDITEX | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.40% | -3.23% | 1.03% |
1-Month | 6.23% | 19.14% | 1.10% |
1-Year | 1.15% | 76.47% | 53.75% |
3-Year CAGR | -12.75% | 6.05% | 14.67% |
5-Year CAGR | 16.32% | 3.59% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ADESHWAR MEDITEX share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ADESHWAR MEDITEX the stake stands at 42.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ADESHWAR MEDITEX.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ADESHWAR MEDITEX paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ADESHWAR MEDITEX.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.